Moderna and Lonza Join to Manufacture Moderna’s Vaccine Against Novel Coronavirus

Moderna, Inc., (Cambridge, MA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, and Lonza Ltd. (Basel, Switzerland) have announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna’s mRNA vaccine (mRNA-1273) against the novel coronavirus (SARS-CoV-2) and additional ...